PetMed Express, Inc. (PETS) is a publicly traded Healthcare sector company. As of July 5, 2026, PETS trades at $1.98 with a market cap of $42.32M and a P/E ratio of -0.72. PETS moved -0.50% today. Year to date, PETS is -39.08%; over the trailing twelve months it is -41.25%. Its 52-week range spans $1.57 to $6.85. Rallies surfaces PETS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PetMed Express Q4 Revenue Drops 15.6% to $42.82M, EPS Loss Narrows: PetMed Express reported a fourth-quarter loss per share of $0.19, improved from a $0.56 loss a year earlier, missing estimates by $0.01. Quarterly revenue fell 15.6% to $42.82 million, while its price-to-earnings ratio remained negative at -0.78 and price-to-sales ratio was 0.25.
| Metric | Value |
|---|---|
| Price | $1.98 |
| Market Cap | $42.32M |
| P/E Ratio | -0.72 |
| EPS | $-2.74 |
| Dividend Yield | 0.30% |
| 52-Week High | $6.85 |
| 52-Week Low | $1.57 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $179.02M |
| Net Income | $-57.29M |
| Gross Margin | 28.05% |
PETS analyst coverage data. Average price target: $0.00.